The Kimber was built wit ha three-stage safety. Michael Dickerson Let’s take a closer look at the Desolve Blak. The model I tested was chambered in 6.5 Creedmoor. The Desolve Blak finish will hold up ...

A matched comparison of two disappearing stents, one of which dissolves as early as 1 to 2 years after implantation, suggests the two platforms perform equally well and result in similar clinical ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** For the ardent hunter, Kimber ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio PARIS — The DESolve NX pivotal trial has ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with single de novo coronary lesions, a ...

PARIS, France—A fully bioresorbable drug-eluting stent (DES) shows low late lumen loss and good safety results at 6 months in patients with de novo coronary lesions, according to findings presented ...

21 May 2013, Paris, France: The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show ...

Elixir Medical's DESolve posted promising results at 12 months.--Courtesy of Elixir Medical Elixir Medical notched more promising results for its DESolve device, keeping vessels clear with low rates ...

Elixir Medical won a CE mark for the DESolve stent.--Courtesy of Elixir Medical While Abbott Laboratories ($ABT) leads the way in the dissolvable stent market ...

Elixir Medical placed its first DESolve drug-eluting stent in a patient in Germany since gaining its CE mark last year. The stent is designed to deliver the anti-proliferative drug novolimus and ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that on Mon., October 12, ...